Prof. Dr. Bernardo Franco-Barcenas | Nanobiotechnology | Best Researcher Award

Posted on by ScienceFather

Prof. Dr. Bernardo Franco-Barcenas | Nanobiotechnology | Best Researcher Award

Full professor at University of Guanajuato, Mexico

Dr. Bernardo Franco-Bárcenas is an accomplished researcher specializing in molecular microbiology, antimicrobial resistance, and nanotechnology-based applications in pathogen control. With a prolific publication record in high-impact journals such as Pathogens, PeerJ, Microorganisms, and Antioxidants, his work spans the study of microbial virulence mechanisms, biosensing technologies, and novel antimicrobial strategies. He has contributed significantly to the understanding of pathogens like Entamoeba histolytica, Pseudomonas aeruginosa, and pathogenic fungi, integrating theoretical and experimental approaches. Notably, his research also explores biologically synthesized nanoparticles and their roles in combating multidrug-resistant organisms. Dr. Franco-Bárcenas frequently collaborates on interdisciplinary projects, emphasizing genomic, proteomic, and biochemical methodologies to unveil insights into microbial survival, adaptation, and pathogenicity. Although he has not registered patents, his impactful body of work, dedication to collaborative science, and ongoing exploration of nanotechnology in microbiology position him as a strong candidate for recognition in international research awards related to nanomaterials and nanotechnology.

Professional Profile

Google Scholar
Scopus Profile
ORCID Profile

Education

Dr. Bernardo Franco-Barcenas holds a robust academic background rooted in the life sciences. Although specific institutional details are not publicly listed, his educational foundation is evident through his proficiency in microbiology, molecular biology, and biochemistry. His advanced training likely includes a doctoral degree, given his full professorship and extensive research output. His education has equipped him with deep knowledge in various experimental and theoretical techniques such as nucleic acid manipulation, synthetic biology, and bioinformatics. Throughout his academic journey, Dr. Franco has cultivated an interdisciplinary perspective, which he integrates into both teaching and research. His scientific rigor and commitment to continuous learning are evident in his ability to lead complex projects and contribute meaningfully to international peer-reviewed journals. This strong educational foundation has been instrumental in shaping his professional career and research contributions to the broader scientific community.

Professional Experience

Dr. Bernardo Franco is a full-time professor at the Universidad de Guanajuato in Mexico, where he teaches undergraduate and graduate courses in subjects including microbiology, immunology, and general biology. His career spans over 20 years in academic research and over 8 years in university-level teaching, reflecting a strong blend of scholarly inquiry and pedagogy. Beyond classroom instruction, he has also served as a mentor for numerous students, guiding them through research and thesis projects. He holds a key editorial role at PeerJ, where he has authored more than 270 publications, reviewed 680 manuscripts, and edited over 4,200 submissions, underscoring his leadership in academic publishing. His technical expertise spans protein purification, microscopy, PCR, and microbial methodologies, which he applies in both lab-based education and collaborative research. This combination of research leadership, editorial influence, and dedicated teaching positions him as a significant figure in the academic life sciences.

Research Interest

Dr. Franco’s research interests are diverse yet tightly integrated across the disciplines of microbiology, molecular biology, parasitology, and biotechnology. His work is particularly focused on understanding microbial interactions, gene regulation, and synthetic biology applications. He employs techniques such as PCR, DNA/RNA extraction, protein purification, and computational bioinformatics to explore complex biological systems. Dr. Franco is also involved in applied sciences, using biotechnological approaches to address environmental and health-related challenges. His interest in parasitology enhances understanding of host-pathogen interactions, while his work in molecular biology contributes to uncovering cellular mechanisms at the genetic level. He is passionate about translational research that can lead to innovations in diagnostics, therapeutics, and sustainable biotechnology. Through collaborations and editorial work, he continuously updates his research scope, ensuring relevance and innovation. His work bridges traditional microbiology with cutting-edge molecular tools, positioning him at the forefront of life sciences research in Latin America.

Award and Honor

While specific named awards and honors have not been disclosed publicly, Dr. Franco’s academic stature and professional activities indicate a high level of recognition. His appointment as a full professor and his substantial editorial responsibility at PeerJ—editing over 4,200 scientific papers—are themselves indicators of scholarly respect and trust. Moreover, his H-index of 19 and i10-index of 30 reflect a strong citation record and enduring impact within his research community. These metrics, commonly used to assess academic influence, underscore the quality and relevance of his contributions. His role as a reviewer for over 680 papers further demonstrates his active engagement with global scientific discourse. It is also likely that he holds institutional commendations and national academic credentials, given his senior academic position in Mexico. Collectively, these accomplishments and roles reflect both peer recognition and an ongoing commitment to academic excellence and mentorship.

Conclusion

In conclusion, Dr. Bernardo Franco is a distinguished academic whose work bridges foundational science and applied biotechnology. As a full professor at the Universidad de Guanajuato, he has influenced countless students and researchers through his teaching, mentorship, and prolific research output. His extensive expertise in microbiology, molecular biology, and parasitology has contributed significantly to scientific understanding and technological development in life sciences. Dr. Franco’s editorial leadership at PeerJ, alongside his substantial publication and review portfolio, illustrates his commitment to scholarly excellence and scientific integrity. Though specific awards are not listed, his impact is measurable through citation indices and professional respect within the academic community. His career serves as a model of integrated teaching, research, and service, underscoring the value of multidisciplinary inquiry and collaboration. Dr. Franco continues to shape the future of bioscience through education, innovation, and dedication to advancing global knowledge.

Publications Top Notes

  • Title: Fabrication and characterization of functionalized chitosan/TiO₂ film composites with antimicrobial properties
    Authors: V.A. Pérez Martínez, N.I. Vargas-Maya, L.R. Rosas-Orta, B. Franco, J. Vallejo-Montesinos
    Year: 2025

  • Title: Theoretical Study of Sphingomyelinases from Entamoeba histolytica and Trichomonas vaginalis Sheds Light on the Evolution of Enzymes Needed for Survival and Colonization
    Authors: F.B. Ramírez-Montiel, S.Y. Andrade-Guillén, A.L. Medina-Nieto, F. Padilla-Vaca, B. Franco
    Year: 2025

  • Title: Avirulent UG10 Entamoeba histolytica mutant derived from HM-1:IMSS strain shows limited genome variability and aberrant 5-methyl cytosine genomic distribution
    Authors: N.I. Vargas-Maya, A.K. Maunakea, F.B. Ramírez-Montiel, F. Padilla-Vaca, B. Franco
    Year: 2024
    Citations: 1

  • Title: Pseudomonas environmental strain produces a DegQ-derived and PDZ domain containing peptide with protease activity
    Authors: F. Vargas-Gasca, B. Franco, N.I. Vargas-Maya, M. Vicente-Gómez, V. Olmedo-Monfil
    Year: 2024

  • Title: High-Throughput Screening Method Using Escherichia coli Keio Mutants for Assessing Primary Damage Mechanism of Antimicrobials
    Authors: J.A. Martínez-Álvarez, M. Vicente-Gómez, R. García-Contreras, F. Padilla-Vaca, B. Franco
    Year: 2024

Dinesh Kumar | Nanobiotechnology | Global Nanotech Impact Award

Posted on by ScienceFather

Assist. Prof. Dr. Dinesh Kumar | Nanobiotechnology | Global Nanotech Impact Award

Assistant Professor (Nano Science and Nano Technology), at Department of Interdisciplinary Sciences, National Institute of Food Technology Entrepreneurship and Management, Kundli, India.

Dr. Dinesh Kumar is a distinguished scientist with over 15 years of experience in the healthcare and biomedical research industry. His expertise spans various domains, including in-vitro diagnostics, food safety, molecular diagnostics, and quality control. He has made significant contributions to the development of rapid point-of-care diagnostic devices, biosensors, and immunoassays for infectious and non-communicable diseases. Dr. Kumar has a strong background in human research studies, epidemiology, biostatistics, and regulatory policies. He has been actively involved in accreditation processes for ISO 17025, ISO 15189, and ISO 13485 standards. His technical proficiency extends to software tools such as SPSS, Prism GraphPad, ChemDraw, and Sigma Plot, which he uses for data analysis and research. His work has been widely recognized, with multiple scientific publications, conference presentations, and collaborations with international regulatory bodies for CE marking and quality assurance. Passionate about innovation in healthcare, he has developed microfluidic test devices and IVD-grade recombinant proteins and antibodies. His research has significantly contributed to advancements in diagnostics, particularly in tuberculosis, antimicrobial resistance, and biomarker detection. Dr. Kumar continues to drive excellence in biomedical research through his technical expertise, innovative mindset, and dedication to improving global healthcare standards.

Professional Profile:

Education

Dr. Dinesh Kumar holds a Ph.D. in Biomedical Sciences from the prestigious Indian Institute of Technology (IIT) Delhi, where his doctoral research focused on developing immunoassays for detecting prednisolone using horseradish peroxidase and colloidal gold as labels. His research provided valuable insights into rapid, specific, and user-friendly diagnostic techniques. He also completed a Master of Science (M.Sc.) in Biochemistry from V M University, where he built a strong foundation in biochemical analysis and laboratory research. His undergraduate education includes a Bachelor of Science (B.Sc.) in Medical Laboratory Technology from V M University, equipping him with essential laboratory and clinical skills. Additionally, Dr. Kumar earned a Diploma in Medical Laboratory Technology (DMLT) from the Para Medical Board of India, further strengthening his expertise in clinical diagnostics. To expand his knowledge in food safety and quality management, he pursued a Postgraduate Diploma in Food Safety & Quality Management (PGDFSQM) from IGNOU, New Delhi. His multidisciplinary academic background has enabled him to integrate various scientific approaches into his research, particularly in molecular diagnostics and immunology. His educational journey reflects his commitment to continuous learning and his ability to bridge the gap between fundamental research and real-world healthcare applications.

Professional Experience

Dr. Dinesh Kumar has amassed extensive experience across multiple dimensions of the healthcare industry, including diagnostics research, quality control, and regulatory compliance. He has worked on mass-scale production and testing of in-vitro diagnostic (IVD) rapid kits, biochemistry kits, and RT-PCR molecular diagnostic kits. His expertise in diagnostics has played a crucial role in the development of innovative point-of-care testing devices. He has also provided technical support for product development in molecular diagnostics, biochemistry, and immunoassays, offering consultancy services to various healthcare organizations and government facilities. His experience in accreditation processes for ISO 17025 and ISO 15189 highlights his role in ensuring high-quality standards in laboratory testing. Dr. Kumar has also been actively involved in project preparation and implementation for government health facilities, focusing on improving diagnostic capabilities in healthcare institutions. His professional journey is marked by collaborations with international regulatory bodies, including those responsible for CE marking and ISO compliance. With a strong background in biostatistics and epidemiology, he has contributed significantly to the research and development of diagnostic tools for infectious diseases, antimicrobial resistance, and biomarkers for conditions such as cancer, cardiovascular diseases, and nephrology. His technical and managerial expertise makes him a leader in biomedical innovation.

Research Interests

Dr. Dinesh Kumar’s research interests lie at the intersection of biomedical diagnostics, molecular biology, and nanotechnology. He is particularly passionate about the development of rapid and cost-effective point-of-care diagnostic devices for communicable and non-communicable diseases. His work focuses on immunoassays, biosensors, microfluidic test devices, and molecular diagnostics, particularly RT-PCR technology for infectious disease detection. He has a keen interest in antimicrobial resistance research, aiming to develop diagnostic solutions that enable early detection and effective treatment of resistant infections. His expertise extends to the study of biomarkers for chronic diseases, including cancer, cardiovascular diseases, and nephrology. Additionally, Dr. Kumar has been actively involved in quality assurance and regulatory compliance for medical diagnostics, ensuring that innovations meet international standards for safety and efficacy. His research also encompasses bioinformatics and computational biology, utilizing advanced statistical and data analysis techniques to enhance diagnostic accuracy. His interest in nanotechnology is reflected in his work on biosensors and microfluidic platforms, which have the potential to revolutionize healthcare diagnostics. By integrating biotechnology, immunology, and analytical chemistry, Dr. Kumar strives to bridge the gap between research and clinical application, making diagnostic technologies more accessible and efficient for global healthcare systems.

Research Skills

Dr. Dinesh Kumar possesses a diverse range of research skills that make him a valuable asset in biomedical and healthcare research. He has expertise in immunoassay development, including enzyme-linked immunosorbent assay (ELISA) and lateral flow immunoassay (LFIA), which are crucial for rapid diagnostics. His technical skills in molecular diagnostics include RT-PCR, real-time PCR, and nucleic acid amplification techniques, making him proficient in detecting infectious diseases at the molecular level. He has extensive experience in biosensor technology, microfluidics, and point-of-care testing, particularly for tuberculosis, antimicrobial resistance, and biomarker detection. Dr. Kumar is also skilled in biostatistics and epidemiological data analysis, using software such as SPSS, Prism GraphPad, ChemDraw, and Sigma Plot. His background in quality control and regulatory compliance enables him to ensure the accuracy and reliability of diagnostic products. He is proficient in Good Laboratory Practices (GLP), Standard Operating Procedures (SOP) development, and accreditation processes for ISO 17025 and ISO 15189. Additionally, he has expertise in protein chemistry, including the development of IVD-grade recombinant proteins and monoclonal and polyclonal antibodies. His ability to integrate biotechnology with analytical techniques and computational tools makes him a well-rounded researcher dedicated to advancing biomedical science and healthcare solutions.

Awards and Honors

Dr. Dinesh Kumar has been recognized for his contributions to biomedical research and diagnostics through various awards and honors. He has received accolades for his innovative research in point-of-care diagnostics, including best oral presentation awards at international conferences. His contributions to immunoassay development and biosensor technology have earned him recognition from scientific communities and regulatory organizations. His expertise in molecular diagnostics and antimicrobial resistance has also been acknowledged through invitations to speak at prestigious global conferences. Dr. Kumar has played a key role in obtaining CE marking and ISO accreditation for various diagnostic products, demonstrating his impact on regulatory and quality assurance standards. His commitment to research excellence has been reflected in numerous publications in high-impact scientific journals. Additionally, his mentorship and training programs in diagnostics and quality control have contributed to capacity building in the healthcare sector. As a result, he has established himself as a leading expert in biomedical innovation, with a track record of excellence in research, development, and regulatory compliance. His awards and recognitions highlight his dedication to improving healthcare through cutting-edge diagnostic technologies and scientific advancements.

Conclusion

Dr. Dinesh Kumar is a highly accomplished scientist whose research has significantly advanced the field of biomedical diagnostics. His expertise in immunoassays, biosensors, and molecular diagnostics has led to the development of innovative point-of-care testing devices that address critical healthcare challenges. His extensive experience in regulatory compliance and quality control has ensured that his innovations meet international standards, making a tangible impact on the healthcare industry. His strong academic background, technical proficiency, and research skills have positioned him as a leader in diagnostic development. Dr. Kumar’s contributions to antimicrobial resistance research and biomarker detection highlight his commitment to improving early disease diagnosis and treatment outcomes. His work in nanotechnology applications, particularly in biosensor development, further enhances his eligibility for prestigious research awards. Through his dedication to innovation and excellence, Dr. Kumar continues to shape the future of biomedical research, bridging the gap between scientific discovery and clinical application to improve global healthcare.

Publication Top Notes

  • TG Shrivastav, SK Chaube, KP Kariya, PKV Prasad, D Kumar – 14 citations (2013)
  • TG Shrivastav, SK Chaube, KP Kariya, R Singh, D Kumar, D Pandit, … – 11 citations (2011)
  • TG Shrivastav, SK Chaube, PKV Prasad, KP Kariya, D Kumar – 10 citations (2012)
  • TG Shrivastav, SK Chaube, KP Kariya, S Bhanot, R Singh, D Kumar – 10 citations (2010)
  • TG Shrivastav, SK Chaube, KP Kariya, R Singh, D Kumar, P Jain, … – 9 citations (2012)
  • D Kumar, H Singh, TG Shrivastav – 8 citations (2018)
  • TG Shrivastav, SK Chaube, KP Kariya, P Kumari, R Singh, D Kumar – 8 citations (2011)
  • TG Shrivastav, KP Kariya, PKV Prasad, SK Chaube, D Kumar – 7 citations (2014)
  • TG Shrivastav, SK Chaube, KP Kariya, D Kumar, R Singh – 5 citations (2011)

 

Mr. Krishan Kumar | Nanobiotechnology Awards | Best Researcher Award

Posted on by ScienceFather

Mr. Krishan Kumar | Nanobiotechnology Awards | Best Researcher Award

Mr. Krishan Kumar, IIT Delhi, India

Krishan Kumar is a dedicated PhD candidate at the Indian Institute of Technology (IIT) Delhi, specializing in the study of regulatory small RNAs in Mycobacterium tuberculosis under acidic stress. With a solid foundation in biochemistry and nanotechnology, he completed an M.Tech from IIT Roorkee and an M.Sc. in Biochemistry from DBRAU, Agra. His diverse research interests span biochemistry, immunology, microbiology, molecular biology, and recombinant DNA technology. Known for his research aptitude, Krishan has published influential papers and has earned awards, including the Research Scholar Travel Award at IIT Delhi and several Best Presentation Awards. Outside academia, he has experience in teaching and research positions and contributes to community initiatives like the Swachh Bharat Internship. As a life member of the Society of Biological Chemists and the American Society for Cell Biology, Krishan is committed to advancing knowledge in biomedical science through innovative research and collaborative efforts.

Professional Profile:

Scopus

Google Scholar

Orcid

Summary of Suitability for the Award:

Krishan Kumar is a highly qualified candidate for the Best Researcher Award, given his comprehensive research background, impactful contributions, and dedication to biomedical science. Currently a PhD candidate at the prestigious Indian Institute of Technology (IIT) Delhi, Krishan focuses on the study of regulatory small RNAs in Mycobacterium tuberculosis under acidic stress—a promising area with potential implications for tuberculosis treatment and understanding pathogen survival mechanisms.

🎓Education :

Krishan Kumar’s academic journey reflects his dedication to life sciences and nanotechnology. He is currently pursuing a PhD at IIT Delhi, where he focuses on the role of regulatory small RNAs in Mycobacterium tuberculosis under acidic stress conditions. His research builds on a strong educational background, including an M.Tech in Nanotechnology from IIT Roorkee, where he graduated with a CGPA of 7.714, and an M.Sc. in Biochemistry from DBRAU, Agra, where he excelled with an 80.9% score and was awarded a Gold Medal at ABVP’s Pratibha Samman Samaroh. His foundational education includes a B.Sc. in Life Sciences from Sri Venkateswara College, Delhi University, with a 69.17% score. Krishan’s academic milestones are complemented by his passion for interdisciplinary research, laying the groundwork for his current and future contributions to the fields of biochemistry and microbiology.

🏢Professional Experience :

Krishan Kumar brings rich experience in research and teaching. At IIT Delhi, he’s pursuing a PhD focusing on regulatory small RNAs in Mycobacterium tuberculosis. Previously, he conducted research in amyloidosis biochemistry at IIT Kanpur, gaining hands-on experience with advanced biochemical analysis. Additionally, Krishan has served as a faculty member in Biochemistry and Biotechnology at DUVASU, Mathura, where he imparted knowledge to aspiring scientists. Beyond academia, he co-founded Genome Biotech Coaching in Agra, guiding students in biotechnology and life sciences. His community engagement includes a Swachh Bharat Summer Internship at IIT Roorkee, where he contributed to environmental and public health initiatives. Krishan’s experience across prestigious institutions and initiatives showcases his dedication to research, teaching, and social responsibility, which have all shaped his multifaceted career in science.

🏅Awards and Honors :

Krishan Kumar has received numerous accolades in recognition of his academic excellence and research contributions. At IIT Delhi, he was awarded the Research Scholar Travel Award and the Research Communications Award in 2024. His academic achievements also include national qualifications, such as GATE (AIR-280 & AIR-235), ICMR-JRF 2015, and NET-2015, demonstrating his strong foundation in life sciences. For his academic performance, Krishan received a Gold Medal at ABVP’s Pratibha Samman Samaroh for achieving the highest M.Sc. percentage. He also earned multiple Best Poster/Oral Presentation Awards at NCRTNFBASE-2020 and ICMRP-2023, further highlighting his research excellence. These honors underscore his commitment to academic excellence, research innovation, and impactful scientific communication, reinforcing his reputation as an emerging researcher in biochemistry and nanotechnology.

🔬Research Focus :

Krishan Kumar’s research focuses on understanding the role of regulatory small RNAs in Mycobacterium tuberculosis under acidic stress, a critical area for uncovering mechanisms of pathogenicity and resilience in tuberculosis. His interdisciplinary expertise in biochemistry, nanotechnology, immunology, microbiology, and molecular biology informs his approach to studying bacterial response mechanisms. Skilled in recombinant DNA technology, Krishan employs advanced techniques, including PCR, EMSA, ELISA, RT-PCR, and SDS-PAGE, to explore molecular interactions and regulatory pathways. His work on amyloidosis biochemistry at IIT Kanpur and his projects on nanoparticle encapsulation for medical applications and algal biodiversity reflect his adaptability and commitment to advancing biomedical research. Through his research, Krishan aims to contribute valuable insights to the understanding of bacterial pathogenesis, potentially informing new therapeutic strategies for tuberculosis and related diseases.

Publication Top Notes:

  1. Title: “A Review of Diagnostic Nano Stents: Part (I)”
    Citations: 9
  2. Title: “The Therapeutic Management of Chemical and Herbal Medications on Uric Acid Levels and Gout: Modern & Traditional Wisdom”
  3. Title: “Transcriptional activation of the Mycobacterium tuberculosis virulence-associated small RNA MTS1338 by the response regulators DosR and PhoP”
  4. Title: “RSM assisted phytochemical profiling of Vitex negundo and molecular docking studies of biologically active compounds with target proteins”
  5. Title: “Unique Characteristics of Adipocytes in Metabolic Health: Insights and Implications”

 

 

Assist. Prof. Dr. Efthymia Iliana Matthaiou | Nanobiotechnology Awards | Best Researcher Award

Posted on by ScienceFather

Assist. Prof. Dr. Efthymia Iliana Matthaiou | Nanobiotechnology Awards | Best Researcher Award

Assist. Prof. Dr. Efthymia Iliana Matthaiou, Albany Medical College, United States

Efthymia Iliana Matthaiou, PhD, is an Assistant Professor at Albany Medical College, NY, specializing in fungal infections and immunology. With a solid background in nanotechnology, immuno-oncology, and drug development, she leads cutting-edge translational research, developing novel therapies and diagnostics. Her expertise spans lung transplantation, cystic fibrosis, and autoimmune diseases. Dr. Matthaiou has a strong commitment to mentoring students, postdocs, and collaborators, and has been a key figure in advancing the study of fungal pathogens, including Aspergillus species. She holds several prestigious fellowships and grants, and has contributed significantly to scientific publications, particularly in the fields of immunology, transplantation, and nanomedicine.

Professional Profile:

Google Scholar

Orcid

Suitability for the “Best Researcher” Award: Efthymia Iliana Matthaiou, PhD

Summary of Suitability:

Dr. Efthymia Iliana Matthaiou is an exceptional candidate for the “Best Researcher” award due to her extensive and pioneering contributions in the fields of microbiology, immunology, and fungal infections. With a PhD from the University of Pennsylvania and Democritus University of Thrace, Dr. Matthaiou has advanced research into the molecular mechanisms of diseases such as cystic fibrosis and invasive fungal infections, focusing on immunomodulatory therapies and bioanalytical strategies.

🎓Education:

Dr. Matthaiou completed her postdoctoral training at Stanford University in 2020, focusing on lung immunology and transplantation. She earned her PhD from the University of Pennsylvania and Democritus University of Thrace in 2017, where her research centered on nanotechnology, immuno-oncology, and drug development. She graduated with the highest honors from Democritus University of Thrace with a BSc in 2011, marking the beginning of her promising scientific career.

🏢Experience:

Dr. Matthaiou is currently an Assistant Professor at Albany Medical College, where she leads a research laboratory focused on fungal infections and lung transplantation. Before this, she was a Lead Senior Scientist at Stanford University, leading several research initiatives on lung microenvironment, cystic fibrosis, and Aspergillus-related diseases. Her work includes developing immunomodulatory nanotherapies and studying host-pathogen interactions. She has also served as a postdoctoral researcher at Stanford, focusing on invasive aspergillosis in pediatric lung transplant patients and mentoring new hires and trainees.

🏅Awards and Honors:

Dr. Matthaiou has received several prestigious awards and fellowships, including the 2024 NCCAT-GUP3 Cryo-EM grant, for which she serves as Principal Investigator. She was also a Fellow of the 2022 Women’s Leadership Innovation Lab and received the 2019 Stanford MCHRI Postdoctoral Award, funding her research on innate immunity defects in cystic fibrosis and Aspergillus infections. These accolades highlight her leadership and contributions to the fields of immunology, transplantation, and infectious diseases.

🔬Research Focus:

Dr. Matthaiou’s research focuses on the intersection of fungal infections, immunology, and nanomedicine. Her work investigates the immune mechanisms that contribute to Aspergillus-related diseases, especially in the context of lung transplantation and cystic fibrosis. She is also exploring novel therapeutic approaches, such as nanoparticle-mediated drug delivery, to treat invasive aspergillosis. In addition, her research delves into macrophage dysregulation and its role in promoting fungal invasion, with the aim of developing immunomodulatory treatments to mitigate infection and improve patient outcomes.

Publication Top Notes:

  • Title: Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancer
    • Cited by: 89
  • Title: Tumor endothelial marker 1–specific DNA vaccination targets tumor vasculature
    • Cited by: 78
  • Title: Iron: an essential nutrient for Aspergillus fumigatus and a fulcrum for pathogenesis
    • Cited by: 40
  • Title: Tumour endothelial marker 1/endosialin-mediated targeting of human sarcoma
    • Cited by: 36
  • Title: The safety and tolerability of pirfenidone for bronchiolitis obliterans syndrome after hematopoietic cell transplant (STOP-BOS) trial
    • Cited by: 17

 

 

 

 

Dr. Konstantina Solou | Nanobiotechnology Awards | Best Researcher Award

Posted on by ScienceFather

Dr. Konstantina Solou | Nanobiotechnology Awards | Best Researcher Award

Dr. Konstantina Solou, University of Patras, Greece

Konstantina Solou, M.D., is a dedicated Resident in Orthopedic Surgery and Traumatology currently practicing at Piraeus General Hospital ‘Tzaneio’. Born on November 29, 1995, in Greece, she has cultivated a passion for advancing orthopedic practices through her clinical work and research. Konstantina is a Ph.D. candidate at the University of Patras, focusing on optimizing the biomechanical behavior of femoral prostheses. With experience as a first surgeon under supervision in trauma surgery, she actively contributes to surgical teams, including knee and hip prostheses and arthroscopies. Konstantina has been involved in multiple research projects, resulting in several publications in reputable medical journals. In addition to her clinical responsibilities, she has been a head counselor at Junior and Teen Camp in Switzerland, showcasing her leadership and mentorship skills. With a commitment to improving patient outcomes, Konstantina continues to pursue excellence in her medical career

Professional Profile:

Orcid

Suitability Summary for the Best Researcher Award

Konstantina Solou is an exemplary candidate for the Best Researcher Award, given her robust educational background, extensive clinical experience, notable achievements, and a focused research agenda in orthopedic surgery. Currently a Ph.D. candidate in Medicine and Biomechanics at the University of Patras, she is dedicated to optimizing femoral prosthesis design through innovative research. Her Master’s degree in Sports and Exercise Science and Medicine from the University of Glasgow, awarded with Distinction, highlights her academic excellence and commitment to her field.

🎓Education :

Konstantina Solou has a robust educational background that includes a diverse range of medical and scientific studies. She is currently a Ph.D. candidate in Medicine and Biomechanics at the University of Patras, with a thesis focused on optimizing porosity distribution in femoral prostheses to enhance biomechanical performance. Prior to her Ph.D., she earned a Master’s Degree in Sports and Exercise Science and Medicine from the University of Glasgow, graduating with Distinction in December 2022. Her foundational education includes a Medical Diploma from the School of Medicine, University of Patras, where she graduated with a grade of Very Good in July 2019. Konstantina also completed her high school education at the 2nd High School of Agrinio, receiving a Very Good grade. This comprehensive educational path has equipped her with the necessary skills and knowledge to excel in orthopedic surgery and research.

🏢Experience:

Konstantina Solou has garnered extensive experience in orthopedic surgery and traumatology through her residency and various clinical rotations. Currently, she serves as a Resident Doctor at Piraeus General Hospital ‘Tzaneio’, where she manages pre- and post-operative care, trauma cases, and performs minor surgical interventions. She actively assists in major surgeries, including knee and hip prostheses and arthroscopies, while also gaining experience as a first surgeon under supervision in trauma surgery. Konstantina has also completed a residency in the Spine Department at Bern University Hospital, enhancing her expertise in spinal injuries. Earlier in her career, she was a Resident Doctor at Patras University Hospital, where she rotated through emergency medicine, intensive care, and general surgery. Additionally, she served as a Head Counselor at Junior and Teen Camp in Switzerland, demonstrating her leadership abilities and commitment to youth development alongside her medical pursuits.

🏅Awards and Honors :

Konstantina Solou has achieved several academic accolades throughout her educational journey. Notably, she earned her Master’s Degree in Sports and Exercise Science and Medicine from the University of Glasgow with Distinction, reflecting her dedication and excellence in her studies. Her medical diploma from the School of Medicine at the University of Patras was awarded with a grade of Very Good, indicating her strong academic performance in medical training. Furthermore, Konstantina’s commitment to research and clinical practice has led to recognition through her published works in reputable medical journals, contributing to the field of orthopedic surgery. While specific awards are not listed, her selection for a Fellowship in Orthopedic Oncology at the prestigious Orthopedic Institute Rizzoli in Bologna, Italy, further emphasizes her excellence and potential in orthopedic surgery. These achievements underscore her ambition and commitment to advancing her expertise in medicine.

🔬Research Focus :

Konstantina Solou’s research focus centers on optimizing biomechanical outcomes in orthopedic surgery, specifically through the development of femoral prostheses. As a Ph.D. candidate at the University of Patras, she is investigating the porosity distribution of short metaphyseal femoral stems. Her research utilizes finite element analysis to enhance the prosthesis’ biomechanical behavior, aiming for performance that closely mimics physiological bone properties. This innovative work seeks to address common challenges in prosthetic design, ultimately improving patient outcomes and longevity of implants. Additionally, Konstantina has contributed to various studies examining postoperative pain management and surgical outcomes, as evidenced by her publications. Her research spans topics such as injury management and surgical techniques, showcasing her commitment to advancing orthopedic practices through evidence-based methodologies. Konstantina’s focus on biomechanics and her clinical experiences position her at the forefront of orthopedic innovation and research.

Publication Top Notes:

  • A Reduction in Tumor Volume Exceeding 65% Predicts a Good Histological Response to Neoadjuvant Chemotherapy in Patients with Ewing Sarcoma
  • Histological and Imaging Features of Myoepithelial Carcinoma of the Bone and Soft Tissue
  • Coracoclavicular Fixation Techniques for Neer IIb and “Extralateral” Fractures of the Distal Clavicle: A Systematic Review
  • Significance of Quadrilateral Plate in Surgical Treatment of Complex Bi-Columnar Acetabular Fractures: Descriptive Analysis through Three Cases

 

 

Mr. Jose M Soriano | Nanobiotechnology Awards | Best Researcher Award

Posted on by ScienceFather

Mr. Jose M Soriano | Nanobiotechnology Awards | Best Researcher Award

Mr. Jose M Soriano, University of Valencia, Spain

José Miguel Soriano del Castillo,  is a distinguished full professor in food safety, toxicology, and nutritional sciences at the Universitat de València. Holding a Licenciatura in Pharmacy and a Ph.D. in Food Safety, he has dedicated his career to advancing public health through food science and toxicology. Soriano is recognized for his extensive research on pathogenic food agents, toxicity in food items, and essential nutrients, making him a key figure in food safety and toxicology. His collaborative work has significantly influenced food quality standards and safety protocols globally. A fluent speaker of Valencian/Catalan, he is a member of various prestigious academic societies and has published extensively in high-impact journals.

Professional Profile:

Orcid

Scopus

 Best Researcher Awards: José Miguel Soriano del Castillo

Summary of Suitability for the Award:

José Miguel Soriano del Castillo’s extensive and impactful research in the fields of food safety, toxicology, and nutritional sciences positions him as an outstanding candidate for the Best Researcher Award. His academic background, which includes a Licenciatura in Pharmacy and a Ph.D. in Food Safety, demonstrates a strong foundation in both theoretical knowledge and practical applications relevant to public health.

🎓Education:

Soriano completed his Licenciatura in Pharmacy at the Facultat de Farmacia, Universitat de València, in 1996. Building on his expertise, he pursued a Ph.D. in Food Safety at the same institution, which he completed in 2001. To further expand his knowledge, he earned a degree in Human Nutrition and Dietetics from Universidad Cardenal Herrera-CEU in 2018. His academic journey reflects a commitment to understanding the intricate relationships between food, nutrition, and public health. With a strong foundation in pharmacy, Soriano specializes in food toxicology and safety, integrating interdisciplinary insights from his studies into his current research and teaching.

🏢Experience:

Soriano began his career in 1996 as a researcher at the Laboratorio de Bromatología, Facultat de Farmacia, Universitat de València, where he conducted essential food safety studies until 2001. His career evolved with his appointment as a full professor on November 15, 2019, at the Universitat de València. In this role, he contributes to the field through research in food science, public health, and toxicology. Soriano has also served in advisory capacities, lending his expertise to enhance food safety regulations in academic and public health institutions. His dedication to education, coupled with his professional achievements, has greatly impacted his department and students.

🏅Awards and Honors:

José Miguel Soriano del Castillo has received numerous accolades for his impactful contributions to food safety and toxicology. His pioneering research on food toxicity and nutritional science has earned him recognition in scientific circles. Among his honors are awards for excellence in public health research and commendations from both national and international academic bodies. His work has been frequently cited in food safety protocols, making him a respected authority in the field. Soriano’s commitment to enhancing food safety and public health has cemented his status as a prominent figure in the scientific community.

🔬Research Focus:

Soriano’s research focuses on identifying and mitigating risks associated with food-borne pathogens, analyzing food toxicity, and assessing essential nutrients. His work aims to improve food safety standards and public health by investigating harmful food contaminants and optimizing detection methods. As a leader in food toxicology, he explores innovative methodologies in high-performance liquid chromatography (HPLC) and other analytical techniques to evaluate pesticides and other hazardous substances in food. His research supports sustainable practices in food production and enhances safety in food supply chains, contributing significantly to public health and nutrition.

Publication Top Notes:

  • NUTRARET: Effect of 2-Year Nutraceutical Supplementation on Redox Status and Visual Function of Patients With Retinitis Pigmentosa: A Randomized, Double-Blind, Placebo-Controlled Trial
    • Citations: 3
  • Nutraceutical supplementation ameliorates visual function, retinal degeneration, and redox status in rd10 mice
    • Citations: 19
  • The BFMNU method as an alternative to the methods in use based on energy: Study of the correlation between food energy and body mass | El método BFMNU como alternativa a los métodos en uso basados en energía: Estudio de la correlación entre la energía alimentaria y la masa corporal
    • Citations: 1
  • Obesity’s causes and treatment | Causas y tratamiento de la obesidad
    • Citations: 16
  • Anthropometric evaluation of adult coeliac patients from de Valencian Community (Spain) | Evaluación antropométrica de celíacos adultos de la Comunidad Valenciana
    • Citations: 1

 

 

Prof. Dr. Salvatore De-Simone | Nanobiotechnology Awards | Best Researcher Award

Posted on by ScienceFather

Prof. Dr. Salvatore De-Simone | Nanobiotechnology Awards | Best Researcher Award

Prof. Dr. Salvatore De-Simone ,Oswaldo Cruz Institute (IOC),Brazil

Salvatore Giovanni De Simone is a prominent biochemist with a distinguished career in the fields of biotechnology, molecular biology, and infectious diseases. He earned his Bachelor of Science in Biomedical Sciences from the State of Rio de Janeiro University (1976), followed by a Master’s (1980) and Doctorate (1986) in Biochemistry from the Federal University of Rio de Janeiro. Throughout his career, Dr. De Simone has held various prestigious positions, including Full Professor of Biochemistry at the Federal Fluminense University and Chief of the Biochemistry of Protein and Peptides Laboratory at the Oswaldo Cruz Institute (FIOCRUZ). He has also served as a visiting researcher at several renowned international institutions. Currently, Dr. De Simone is a Specialist in Science and Technology Production and Innovation in Health at the Oswaldo Cruz Foundation and a member of the National Institute of Neglected Population Diseases of Brazil. His research focuses on antimicrobial peptides, protein structure, and immunological diagnostics, and he has published extensively on these topics. Dr. De Simone has supervised numerous graduate students and postdoctoral researchers and has coordinated significant national and international research projects and symposiums.

Professional Profile:

Scopus

Orcid

Suitability for the “Best Researcher Award” – Summary and Conclusion

Candidate: Salvatore Giovanni De Simone

Summary of Suitability: Salvatore Giovanni De Simone is an accomplished scientist with an extensive background in biochemistry, molecular biology, and infectious diseases. His career spans over four decades, highlighted by significant contributions to academia, research, and scientific innovation. De Simone has held prestigious positions, including Full Professor of Biochemistry at the Federal Fluminense University and Chief of the Biochemistry of Protein and Peptides Laboratory at the Oswaldo Cruz Institute. His work has led to numerous advancements in understanding and combating infectious diseases, particularly through the study of protein structures, antimicrobial peptides, and the development of diagnostic tools.

🎓Education:

Salvatore Giovanni De Simone holds a Bachelor of Science in Biomedical Sciences from the State of Rio de Janeiro University, completed in 1976. He further advanced his education by earning a Master of Science in Biochemistry in 1980, followed by a Doctor of Science in Biochemistry in 1986, both from the Federal University of Rio de Janeiro

🏢Work Experience:

Salvatore Giovanni De Simone has held numerous prestigious positions throughout his career. He is currently a Specialist in Science and Technology Production and Innovation in Health at the Center for Technological Development in Health (CDTS) at the Oswaldo Cruz Foundation in Rio de Janeiro, Brazil. Previously, he served as a Full Professor of Biochemistry at the Federal Fluminense University in Niterói, Rio de Janeiro, from 1984 to 2012. He also led the Biochemistry of Protein and Peptides Laboratory at the Oswaldo Cruz Institute (FIOCRUZ) from 1992 to 2012. In addition to his roles in Brazil, Dr. De Simone has gained international experience as a Visiting Researcher at the Laboratory of Genic Recombination at the Institut d’Hematologie-Centre Hayem, Hopital St. Louis in Paris, France, in 1987; at the Department of Medical Parasitology at New York University (NYU) in the United States from 1988 to 1989; and at the European Molecular Biology Laboratory (EMBL) in Germany in 1990.

🏅Awards and Honors:

Salvatore Giovanni De Simone has been recognized with several notable awards and positions throughout his career. He has received the Researcher Productivity Award (Category 1C) from the National Council of Scientific and Technological Development (CNPq) in Brazil and has been honored as a Scientist of the State of Rio de Janeiro by the Foundation for Research Support of the State of Rio de Janeiro (FAPERJ). Dr. De Simone also coordinated the Peptide Synthesis Platform at the Oswaldo Cruz Foundation from 1992 to 2012. Additionally, he served as a member of the Assessment Committee in Biotechnology for the National Council of Research from Brazil (CNPq) during the 2022-2023 term.

Publication Top Notes:

  • Title: Development of an Electrochemical Immunosensor for the Diagnostic Testing of Spotted Fever Using Synthetic Peptides
    • Citations: 18
  • Title: Cryptosporidium spp. Contamination in Perna perna Mussels Destined for Human Consumption in Southeastern Rio de Janeiro, Brazil
    • Citations: 7
  • Title: Ultrasensitive and Rapid Immuno-detection of Human IgE Anti-therapeutic Horse Sera Using an Electrochemical Immunosensor
    • Citations: 9
  • Title: Development of an ELISA for the Diagnosis of Reactive IgE Antibodies Anti-therapeutic Horse Sera
    • Citations: 10
  • Title: Oligopeptidase B and B2: Comparative Modelling and Virtual Screening as Searching Tools for New Antileishmanial Compounds
    • Citations: 11

 

 

 

 

Assist. Prof. Dr. Israa M.S. Al-Kadmy | Nanobiotechnology Awards | Women Researcher Award

Posted on by ScienceFather

Assist. Prof. Dr. Israa M.S. Al-Kadmy | Nanobiotechnology Awards | Women Researcher Award

Assist. Prof. Dr. Israa M.S. Al-Kadmy ,Al-Mustansiriya University \ College of Science \ Department of Life Sciences , Iraq

Israa Mohammed Safa Abd Ali AL-Kadmy, born on November 30, 1984, in Baghdad, Iraq, is an accomplished researcher and academic in the fields of microbiology and nanotechnology. She earned her BSc in Biology and an MSc in Microbiology from Mustansiriyah University, Iraq. Her academic career includes positions as Assistant Lecturer, Lecturer, and Assistant Professor at various institutions, with a focus on biotechnology, molecular biology, and nanobiotechnology. She has been a Visiting Academic at Plymouth University and has taught courses at Queen’s University Belfast, Lancaster University, and Teesside University. Her research interests include molecular microbiology, nano-biotechnology, and graphene-based biosensors. Dr. AL-Kadmy is actively involved in numerous professional societies and has participated in various international conferences. She is dedicated to advancing the field of nanomaterials and their applications in health care and environmental sustainability.

Professional Profile:

Scopus

Orcid

Summary of Suitability for the Research for Women Researcher Award

Candidate: Israa Mohammed Safa Abd Ali Al-Kadmy

Israa Al-Kadmy’s dedication to advancing nanobiotechnology, her comprehensive teaching and research experience, and her active involvement in scientific communities make her an exemplary candidate for the Research for Women Researcher Award. Her work not only contributes to scientific knowledge but also has practical implications for healthcare and biosensor technologies. Her achievements in a challenging field, combined with her active engagement in both academic and charitable activities, highlight her as a leading female researcher making a meaningful impact in her domain.

🎓Education:

Israa Mohammed Safa Abd Ali AL-Kadmy completed her undergraduate studies with a Bachelor of Science in Biology from Mustansiriyah University, College of Science, Iraq, in 2006. She pursued her postgraduate education at the same institution, earning a Master of Science in Microbiology in 2012. Her MSc thesis focused on the “Detection of 16S rRNA Methylation Gene between Two Species of Gram Negative with High-Level Resistance to Aminoglycosides,” reflecting her deep engagement with molecular microbiology and resistance mechanisms

🏢Work Experience:

Israa Mohammed Safa Abd Ali AL-Kadmy has held several notable academic and research positions across prestigious institutions. She has been an Assistant Professor at Mustansiriyah University, Iraq, since May 2020. Prior to this, she served as a Lecturer at Teesside University, UK, from October 2021 to September 2022, where she taught modules on Sustainability in Chemical Engineering and Environmental and Sustainable Processing. She is currently a Lecturer in Chemical Engineering at Lancaster University, UK, starting in September 2022, where she covers Hydrogen and Fuel Cell Technologies and Chemical Process Design Project

🏆Awards and Honors:

Israa Mohammed Safa Abd Ali AL-Kadmy is an active member of several esteemed professional societies. She is affiliated with the Biological Organization Iraqis, the Science and Engineering Institute (SCIEI), and the Iraqi Society of Nanotechnology STAF ID. Her involvement extends to the International Society for Development and Sustainability (ISDS), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), and the Global Research & Development Services (GRDS). Additionally, she is a member of the European Biosafety Association (EBSA), the British Ecological Society (BES), the Microbiological Society in Europe, and the British Society for Immunology (BSI). Her participation in these organizations underscores her commitment to advancing research and development in her fields of expertise.

Publication Top Notes:

  • Sequencing Analysis and Efficient Biodiesel Production by Lipase from Pseudomonas aeruginosa“
    Citations: 1
  • “The Secrets of Environmental Pseudomonas aeruginosa in Slaughterhouses: Antibiogram Profile, Virulence, and Antibiotic Resistance Genes”
    Citations: 1
  • “The Predominance of Virulence Genes Associated with Multidrug-Resistant Serratia marcescens Isolated from Urinary Tract Infections”
  • “Reducing Environmental Pollutants of Chicken Feathers by Production and Biodegradation of the Chicken Feather Keratinase from Aspergillus niger and Its Role as the Anti-biofilm Activity”
  • “COVID-19 Associated Mucormycosis Among ICU Patients: Risk Factors, Control, and Challenges”

 

 

 

 

Prof. Konstantoula Akrida-Demertzi | Nanobiotechnology Awards | Best Researcher Awards

Posted on by ScienceFather

Prof. Konstantoula Akrida-Demertzi | Nanobiotechnology Awards | Best Researcher Awards

Prof. Konstantoula Akrida-Demertzi,University of Ioannina,Greece

Dr. Konstantoula Akrida-Demertzi is a distinguished scholar with a robust background in food chemistry and technology. She holds a PhD from the University of Ioannina and has held various academic positions at the University of Ioannina, including Lecturer, Assistant Professor, and Associate Professor until her retirement in 2018. Her research spans diverse areas such as food and beverage quality control, food biotechnology, and food microbiology. Dr. Akrida-Demertzi has authored numerous publications in international journals and books, focusing on topics ranging from fermentation processes to food preservation. She has actively contributed to academia through supervising doctoral and master’s theses, as well as participating in numerous scientific committees and workshops. Dr. Akrida-Demertzi’s expertise and leadership extend to her roles in professional associations, reflecting her dedication to advancing food science both nationally and internationally.

Professional Profile:

Google Scholar

🎓Education:

Dr. Konstantoula Akrida-Demertzi earned her PhD from the University of Ioannina, specializing in the dynamic field of Food Chemistry and Technology. Her doctoral studies provided a robust foundation for her subsequent academic and research career, equipping her with deep expertise in understanding the complexities of food composition, processing, and preservation. This educational background enabled Dr. Akrida-Demertzi to contribute significantly to the fields of food quality control, biotechnology, and microbiology throughout her career. Her research has encompassed diverse areas such as fermentation processes and innovative methods in food preservation, reflecting her commitment to advancing scientific knowledge in food science.

🏅Professional Experience :

At the University of Ioannina, Dr. Konstantoula Akrida-Demertzi held a distinguished academic career spanning multiple roles. Beginning as a Lecturer, she imparted knowledge and guidance to students in the field of Food Chemistry and Technology. Through her expertise and dedication, she progressed to the position of Assistant Professor, where she continued to deepen her impact on both research and teaching. Recognized for her contributions and leadership, Dr. Akrida-Demertzi eventually attained the rank of Associate Professor, a position she held until her retirement in 2018. Her tenure at the university was marked by significant scholarly achievements, mentorship of students, and contributions to the academic community, reinforcing her reputation as a respected authority in food science.

🧪 Research Area:

Dr. Konstantoula Akrida-Demertzi’s research career has been distinguished by her extensive contributions to several critical areas within food science. Her expertise spans food and beverage quality control, where she has focused on ensuring the safety, consistency, and nutritional value of food products. In the realm of food biotechnology, Dr. Akrida-Demertzi has explored innovative methods to enhance food production and improve its nutritional content through biotechnological applications. Her work in food microbiology has been instrumental in understanding microbial interactions in food ecosystems, crucial for food safety and preservation strategies.

Publication Top Notes:

  1. Title: A study on the migration of organic pollutants from recycled paperboard packaging materials to solid food matrices
    • Cited By: 250
  2. Title: Differences in concentration of principal volatile constituents in traditional Greek distillates
    • Cited By: 235
  3. Title: Migration studies from recycled paper packaging materials: development of an analytical method for rapid testing
    • Cited By: 90
  4. Title: Isolation of microbial pathogens of subclinical mastitis from raw sheep’s milk of Epirus (Greece) and their role in its hygiene
    • Cited By: 82
  5. Title: Determination of partition behavior of organic surrogates between paperboard packaging materials and air
    • Cited By: 74

 

Dr. Priyanka Singh | Nanobiotechnology Awards | Most Cited Paper Award

Posted on by ScienceFather

Dr. Priyanka Singh | Nanobiotechnology Awards | Most Cited Paper Award

Dr. Priyanka Singh , Denmark Technical University , Denmark

Dr. Priyanka Singh is a Senior Researcher at the Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark. With over seven years of post-doctoral experience, she specializes in green nanoscience and medical biology, focusing on innovative drug development for cancer and infections. Dr. Singh holds a Ph.D. in Nanoscience from Kyung Hee University and has secured substantial external funding for her pioneering research in nanomaterials. She is also committed to mentoring Ph.D. students and fostering interdisciplinary collaborations to advance cell biology and translate research into impactful outcomes.

Professional Profile:

Google Scholar

Education:

Dr. Priyanka Singh earned her Ph.D. in Nanoscience from Kyung Hee University, South Korea, in 2016, where she designed nanoparticles and drug conjugates/nanoformulations to enhance the pharmacokinetics of poorly water-soluble drugs for cancer and infectious cells. She holds a Diploma in Transformational Leadership Programme-Leading Women from CBS, Denmark, completed in November 2020. Dr. Singh has acquired several certifications from the University of Wisconsin–Madison, USA, including physiological characterization, solubilization, and solid form screening for drugs (2022), biologics (2021), drug development processes and CMC aspects (2021), and preclinical and phase 1 oral drug formulations (2021). Additionally, she completed a Teaching Lab course at DTU in January 2022, focused on university-level teaching and learning. Her academic background also includes a Master’s in Microbiology from CSJMU, India (2008-2010), and a Bachelor’s in Microbiology from Kachchh University, India (2005-2008).

Work Experience:

Dr. Priyanka Singh is a Senior Researcher at the Center for Biosustainability, Technical University of Denmark, since December 2023. She leads studies on developing nanomaterials for anticancer and antimicrobial drugs, publishing in high-impact journals, and supervises Ph.D. students in hands-on development of these materials. She is also leading a project on “graphene-based solutions for marine biofilm inhibition” and employs advanced techniques like Flow cytometry, SEM, TEM, and Incucyte for characterizing nanomaterials in various disease models. From January 2021 to November 2023, as a Researcher at the same center, she led a team advancing nanomaterials in medical applications, focusing on biologics formation and characterization, investigating their impact on cancer cells, and enhancing their therapeutic potential.

Publication Top  Notes: